J9063
HCPCSInj, elahere, 1 mg
Official HCPCS Level II long descriptor
Injection, mirvetuximab soravtansine-gynx, 1 mg
HCPCS Level II code J9063 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, elahere, 1 mg
Added to HCPCS: 2023-07-01
Nearby codes in J9
- J9053Inj belantamab mafodot blmf
- J9054Inj bortezomib boruzu 0.1 mg
- J9055Cetuximab injection
- J9056Inj, vivimusta, 1 mg
- J9057Inj., copanlisib, 1 mg
- J9060Cisplatin 10 mg injection
- J9061Inj, amivantamab-vmjw
- J9062Inj amivantamab 5mg hyaluron
- J9064Inj, cabazitaxel (sandoz)
- J9065Inj cladribine per 1 mg
- J9071Inj cyclophosphamd auromedic
- J9072Inj cyclophos frindovyx 5 mg
- J9073Inj cyclophos dr reddys 5 mg
- J9074Inj, cyclophosphamd, sandoz
- J9075Inj, cyclophosphamide, nos
- J9076Inj, cyclophos (baxter) 5mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.